Companies/Chosa Oncology AB
Follow

Chosa Oncology AB

Spotlight Stock Market (Sweden)

Chosa Oncology is focused on the development of vaccines for the treatment of metastatic cancer. Immunotherapy treatment is a significant part of the operations where the body's immune system is used to fight and eliminate cancer cell. The company's drug candidate is used in combination with surgery or radiation therapy.
Go to market

Sector:
HEALTH CARE
Media
Showing 3 of 14
View all
www.chosaoncology.com
Current instruments
Type
Ticker
ISIN
SHARE
CHOSA
SE0007784319
Spotlight Stock Market Sweden (SE)
Top
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
CHOSA
SE0007784319
Spotlight Stock Market
Sweden (SE)
Details of share in Chosa Oncology AB with ticker CHOSA
Status
Active
Currency
SEK
First trading date
09 Mar 2016
Exercise
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Set-off issue
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
RHOVAC
SE0007784319
Spotlight Stock Market
Sweden (SE)
Details of share in Chosa Oncology AB with ticker RHOVAC
Status
Archived
Currency
SEK
First trading date
09 Mar 2016
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Set-off issue
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
CHOSA
SE0007784319
Spotlight Stock Market
Sweden (SE)
Details of share in Chosa Oncology AB with ticker CHOSA
Status
Active
Currency
SEK
Type
Ticker
ISIN
Market
OPTION
RHOVAC TO1
SE0007784327
Spotlight Stock Market
Sweden (SE)
Details of option in Chosa Oncology AB with ticker RHOVAC TO1
Status
Archived
Currency
SEK
Trading period
09 Mar 2016 - 02 Dec 2016
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for SEK 8.30 during the period from November 11, 2016 - December 06, 2015.
Update (09.09.2016): Information about warrants TO1.
Update (15.11.2016): Subscription period for warrants TO1 begins today.
Exercise
Sign in to buy
People
Peter Buhl Jensen
CEO
Neil Goldsmith
Chairman of the board
Ingrid Atteryd Heiman
Board member
Lars Hedbys
Board member
Claus Frisenberg Pedersen
Board member
Ulla Hald Buhl
Board member
Company Details
Sector
HEALTH CARE
Website
Address
Scheeletorget 1
Zip code
223 81
City/district
Lund
Country
Sweden (SE)
Phones
Email
[email protected]
Registration number
559037-2271
LEI code
5493002SFL9YXB0A0027
First trade date
09 Mar 2016
Company former names
RhoVac AB
15 Feb 2023
Registration date
25 Nov 2015
Short name
CHOSA

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More